Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
Apr 15, 2026, 4:00 PM EST
Nuo Therapeutics Employees
Nuo Therapeutics had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
$331,351
Profits / Employee
-$251,222
Market Cap
72.44M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 1 | 11.11% | 10 | 0 |
| Dec 31, 2024 | 9 | 0 | - | 9 | 0 |
| Dec 31, 2023 | 9 | -1 | -10.00% | 9 | 0 |
| Dec 31, 2022 | 10 | 5 | 100.00% | 10 | 0 |
| Dec 31, 2021 | 5 | - | - | 4 | 1 |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 88 |
| Vaxart | 65 |
| Harvard Apparatus Regenerative Technology | 8 |
| Provectus Biopharmaceuticals | 6 |
| Anebulo Pharmaceuticals | 3 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
Nuo Therapeutics News
- 1 year ago - Nuo Therapeutics Announces Exclusive Private Label Distribution Agreement with Smith+Nephew - GlobeNewsWire
- 1 year ago - Nuo Therapeutics and PAM Health Partner to Advance Access to Regenerative Wound Healing Therapies - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Selected to Exhibit Aurix® System at Vizient Innovative Technology Exchange - GlobeNewsWire
- 3 years ago - Nuo Therapeutics' Aurix® System Added To Wound Care Formulary Of Wound Care Advantage - GlobeNewsWire
- 3 years ago - Nuo Therapeutics Provides Corporate and Business Update - GlobeNewsWire